Mahasindod, Camilo H.
HRN: 27-10-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2025
CEFTRIAXONE 1G (VIAL)
05/10/2025
05/17/2025
IV
1g
Q12
Mild TBI Sec To Road Crash Incident
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes